Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, May 23 2023

Full Issue

FDA Approves Another Nasal Spray To Reverse Overdoses

Opvee is similar to naloxone, a drug that has been used for decades to quickly counter overdoses of heroin, fentanyl, and prescription painkillers. In other news, President Joe Biden asks Congress to pass a bill to reduce fentanyl trafficking.

AP: New Nasal Spray To Reverse Fentanyl And Other Opioid Overdoses Gets FDA Approval

The Food and Drug Administration endorsed Opvee, a nasal spray update of the drug nalmefene, which was first approved as an injection in the mid-1990s but later removed from the market due to low sales. Naloxone comes as both a nasal spray and injection. It’s not immediately clear how the new drug will be used differently compared to naloxone, and some experts see potential downsides to its longer-acting effect. (Perrone, 5/22)

In other news on the opioid crisis —

Axios: Biden: Congress Must Pass GOP-Led Fentanyl Bill

The Biden administration called on Congress Monday to pass a bill aimed at tackling fentanyl trafficking in the U.S., which would see the synthetic opioid raised to the highest classification of illegal drugs. The administration's public support for the Republican-led Halt All Lethal Trafficking of (HALT) Fentanyl Act comes amid a growing synthetic opioid crisis in the U.S. (Habeshian, 5/23)

San Francisco Chronicle: Mayor London Breed To Answer Questions About Drug Crisis At Hot Spot

The political tussle over how to handle San Francisco’s drug crisis will get perhaps its most public airing in memory Tuesday when the Board of Supervisors holds a question-and-answer forum on the topic in UN Plaza with Mayor London Breed. The plaza has been one of the worst hotspots for open-air drug dealing and using for decades, and Board of Supervisors President Aaron Peskin said that made it the best spot for the board’s monthly Q&A session with the mayor. (Fagan, 5/22)

KFF Health News: California’s Fentanyl Problem Is Getting Worse

California has allocated more than $1 billion in recent years to combat its opioid crisis. Much of the money has been used to distribute fentanyl test strips and the overdose reversal drug naloxone, as well as deliver medical care to people who are homeless. The state has an opioid awareness campaign tailored to youths and recently called on the National Guard to help detect drug traffickers. Yet the problem keeps getting worse. (Thompson, 5/23)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF